Doleshal Martina, Magotra Amber A, Choudhury Bhavna, Cannon Brian D, Labourier Emmanuel, Szafranska Anna E
Asuragen, Inc., Austin, TX 78744, USA.
J Mol Diagn. 2008 May;10(3):203-11. doi: 10.2353/jmoldx.2008.070153. Epub 2008 Apr 10.
Histopathology archives of well-annotated formalin-fixed, paraffin-embedded (FFPE) tissue specimens are valuable resources for retrospective studies of human diseases. Since recovery of quality intact mRNA compatible with molecular techniques is often difficult due to degradation, we evaluated microRNA (miRNA), a novel class of small RNA molecules with growing therapeutic and diagnostic potential, as an alternative analyte for gene expression studies of FFPE samples. Analyzing total RNA yield, miRNA recovery, and robustness of real-time polymerase chain reaction for miRNA, mRNA, and rRNA species, we compared the performance of commercially available RNA isolation kits and identified a preferred methodology. We further implemented modifications to increase tissue throughput and incorporate a quantitative Armored RNA process control to monitor RNA recovery efficiency. The optimized process was tested for reproducibility as well as interoperator and interday variability, and was validated with a set of 30 clinical samples. In addition, we demonstrated that, independent of FFPE block age and RNA quality, miRNAs generate quantitative reverse transcription-polymerase chain reaction signals that are more robust and better correlate with expression levels from frozen reference samples compared with longer mRNAs. Our broad study, including a total of 272 independent RNA isolations from 17 tissue types and 65 FFPE blocks up to 12 years old, indicates that miRNAs are not only suitable but are also likely superior analytes for the molecular characterization of compromised archived clinical specimens.
注释详尽的福尔马林固定石蜡包埋(FFPE)组织标本的组织病理学档案是人类疾病回顾性研究的宝贵资源。由于降解常常导致难以获得与分子技术兼容的高质量完整mRNA,我们评估了微小RNA(miRNA),这是一类新型的小RNA分子,其治疗和诊断潜力不断增加,作为FFPE样本基因表达研究的替代分析物。通过分析总RNA产量、miRNA回收率以及miRNA、mRNA和rRNA物种的实时聚合酶链反应的稳健性,我们比较了市售RNA分离试剂盒的性能并确定了一种优选方法。我们进一步进行了改进以提高组织通量,并纳入了定量装甲RNA过程控制以监测RNA回收效率。对优化后的过程进行了可重复性以及操作者间和日间变异性测试,并用一组30个临床样本进行了验证。此外,我们证明,与较长的mRNA相比,无论FFPE块的保存时间和RNA质量如何,miRNA产生的定量逆转录-聚合酶链反应信号更稳健,并且与冷冻参考样本的表达水平相关性更好。我们广泛的研究,包括从17种组织类型和65个长达12年的FFPE块中总共进行272次独立的RNA分离,表明miRNA不仅适用于受损存档临床标本的分子特征分析,而且可能是更优的分析物。